SMAD2 and cancer: We followed up on the consequences of some of the mutations and showed characteristic changes in miRNA profiles resulting from specific mutation types in DICER1, SMAD4 and SMAD2. We also showed the associations of the mutations with cancer characteristics and patient survival.